LAPS-IFNα (HM10660A) / Hanmi  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LAPS-IFNα (HM10660A) / Hanmi
NCT02057887: Safety,Tolerability and Pharmacokinetic Study of Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients (HM10660A)

Unknown status
1/2
64
RoW
HM10660A, Laps-IFNa, Pegasys
Hanmi Pharmaceutical Company Limited
Chronic Hepatitis C Virus Genotype I
08/14
 

Download Options